Cargando…

V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism

PURPOSE: The purpose of the study was to assess the prevalence of pulmonary embolism (PE) and other lung diseases among pregnant women with suspected PE and to calculate the radiation exposure to patient and fetus in this population. As a secondary aim, we evaluated the negative predictive value of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajc, Marika, Olsson, Berit, Gottsäter, Anders, Hindorf, Cecilia, Jögi, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480826/
https://www.ncbi.nlm.nih.gov/pubmed/25916742
http://dx.doi.org/10.1007/s00259-015-3056-z
_version_ 1782378196604289024
author Bajc, Marika
Olsson, Berit
Gottsäter, Anders
Hindorf, Cecilia
Jögi, Jonas
author_facet Bajc, Marika
Olsson, Berit
Gottsäter, Anders
Hindorf, Cecilia
Jögi, Jonas
author_sort Bajc, Marika
collection PubMed
description PURPOSE: The purpose of the study was to assess the prevalence of pulmonary embolism (PE) and other lung diseases among pregnant women with suspected PE and to calculate the radiation exposure to patient and fetus in this population. As a secondary aim, we evaluated the negative predictive value of a normal ventilation/perfusion single photon emission computed tomography (V/P SPECT) examination in pregnancy. METHODS: We studied all 127 pregnant women who had suspected PE and had undergone V/P SPECT at our institution in the course of a 5-year period. Radiation exposure to patient and fetus and the negative predictive value of a normal V/P SPECT examination were also measured. RESULTS: V/P SPECT identified PE in 11 women (9 %). Moreover, in 15 women (12 %) the examination revealed pneumonia (in 2 cases in addition to PE) and in 1 woman signs of airway obstruction were revealed. Among the 116/127 women (91 %) where PE was ruled out by V/P SPECT, none was diagnosed subsequently with PE or deep venous thrombosis (DVT) during the same pregnancy or puerperal period. For P SPECT, the calculated fetal absorbed dose was < 0.6 mGy,and the calculated breast absorbed dose 0.6 mGy. For V SPECT, the calculated fetal absorbed dose was < 0.014 mGy and the breast absorbed dose 0.25 mGy. CONCLUSION: The prevalence of PE was low (9 %) among pregnant women with suspected disease. Pneumonia was diagnosed in 12 % of patients. The negative predictive value of V/P SPECT was high, and the radiation exposure from V/P SPECT was low both for fetus and patient.
format Online
Article
Text
id pubmed-4480826
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-44808262015-07-02 V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism Bajc, Marika Olsson, Berit Gottsäter, Anders Hindorf, Cecilia Jögi, Jonas Eur J Nucl Med Mol Imaging Original Article PURPOSE: The purpose of the study was to assess the prevalence of pulmonary embolism (PE) and other lung diseases among pregnant women with suspected PE and to calculate the radiation exposure to patient and fetus in this population. As a secondary aim, we evaluated the negative predictive value of a normal ventilation/perfusion single photon emission computed tomography (V/P SPECT) examination in pregnancy. METHODS: We studied all 127 pregnant women who had suspected PE and had undergone V/P SPECT at our institution in the course of a 5-year period. Radiation exposure to patient and fetus and the negative predictive value of a normal V/P SPECT examination were also measured. RESULTS: V/P SPECT identified PE in 11 women (9 %). Moreover, in 15 women (12 %) the examination revealed pneumonia (in 2 cases in addition to PE) and in 1 woman signs of airway obstruction were revealed. Among the 116/127 women (91 %) where PE was ruled out by V/P SPECT, none was diagnosed subsequently with PE or deep venous thrombosis (DVT) during the same pregnancy or puerperal period. For P SPECT, the calculated fetal absorbed dose was < 0.6 mGy,and the calculated breast absorbed dose 0.6 mGy. For V SPECT, the calculated fetal absorbed dose was < 0.014 mGy and the breast absorbed dose 0.25 mGy. CONCLUSION: The prevalence of PE was low (9 %) among pregnant women with suspected disease. Pneumonia was diagnosed in 12 % of patients. The negative predictive value of V/P SPECT was high, and the radiation exposure from V/P SPECT was low both for fetus and patient. Springer Berlin Heidelberg 2015-04-28 2015 /pmc/articles/PMC4480826/ /pubmed/25916742 http://dx.doi.org/10.1007/s00259-015-3056-z Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Bajc, Marika
Olsson, Berit
Gottsäter, Anders
Hindorf, Cecilia
Jögi, Jonas
V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title_full V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title_fullStr V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title_full_unstemmed V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title_short V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
title_sort v/p spect as a diagnostic tool for pregnant women with suspected pulmonary embolism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480826/
https://www.ncbi.nlm.nih.gov/pubmed/25916742
http://dx.doi.org/10.1007/s00259-015-3056-z
work_keys_str_mv AT bajcmarika vpspectasadiagnostictoolforpregnantwomenwithsuspectedpulmonaryembolism
AT olssonberit vpspectasadiagnostictoolforpregnantwomenwithsuspectedpulmonaryembolism
AT gottsateranders vpspectasadiagnostictoolforpregnantwomenwithsuspectedpulmonaryembolism
AT hindorfcecilia vpspectasadiagnostictoolforpregnantwomenwithsuspectedpulmonaryembolism
AT jogijonas vpspectasadiagnostictoolforpregnantwomenwithsuspectedpulmonaryembolism